Geldenhuys WJ - Search Results

1

Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.

Geldenhuys WJ, Kuzenko SR, Simmons MA. Geldenhuys WJ, et al. J Med Chem. 2010 Nov 25;53(22):8080-8. doi: 10.1021/jm1010012. Epub 2010 Nov 3. J Med Chem. 2010. PMID: 21047106

2

Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.

Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD. Geldenhuys WJ, et al. Bioorg Med Chem Lett. 2004 Jun 21;14(12):3085-92. doi: 10.1016/j.bmcl.2004.04.020. Bioorg Med Chem Lett. 2004. PMID: 15149650

3

Synthesis, biological evaluation, and molecular modeling of novel thioacridone derivatives related to the anticancer alkaloid acronycine.

Dheyongera JP, Geldenhuys WJ, Dekker TG, Van der Schyf CJ. Dheyongera JP, et al. Among authors: geldenhuys wj. Bioorg Med Chem. 2005 Feb 1;13(3):689-98. doi: 10.1016/j.bmc.2004.10.051. Bioorg Med Chem. 2005. PMID: 15653336

4

Antimalarial activity of thioacridone compounds related to the acronycine alkaloid.

Dheyongera JP, Geldenhuys WJ, Dekker TG, Matsabisa MG, Van der Schyf CJ. Dheyongera JP, et al. Among authors: geldenhuys wj. Bioorg Med Chem. 2005 Mar 1;13(5):1653-9. doi: 10.1016/j.bmc.2004.12.009. Bioorg Med Chem. 2005. PMID: 15698783

5

3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.

Geldenhuys WJ, Lockman PR, Nguyen TH, Van der Schyf CJ, Crooks PA, Dwoskin LP, Allen DD. Geldenhuys WJ, et al. Bioorg Med Chem. 2005 Jul 1;13(13):4253-61. doi: 10.1016/j.bmc.2005.04.020. Bioorg Med Chem. 2005. PMID: 15878282

6

Structure-activity relationships of pentacycloundecylamines at the N-methyl-d-aspartate receptor.

Geldenhuys WJ, Malan SF, Bloomquist JR, Van der Schyf CJ. Geldenhuys WJ, et al. Bioorg Med Chem. 2007 Feb 1;15(3):1525-32. doi: 10.1016/j.bmc.2006.09.060. Epub 2006 Sep 29. Bioorg Med Chem. 2007. PMID: 17157509

7

Serotonin 5-HT6 receptor antagonists for the treatment of Alzheimer's disease.

Geldenhuys WJ, Van der Schyf CJ. Geldenhuys WJ, et al. Curr Top Med Chem. 2008;8(12):1035-48. doi: 10.2174/156802608785161420. Curr Top Med Chem. 2008. PMID: 18691131 Review.

8

The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.

Geldenhuys WJ, Van der Schyf CJ. Geldenhuys WJ, et al. Expert Rev Neurother. 2009 Jul;9(7):1073-85. doi: 10.1586/ern.09.51. Expert Rev Neurother. 2009. PMID: 19589055 Review.

9

Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Geldenhuys WJ, Manda VK, Mittapalli RK, Van der Schyf CJ, Crooks PA, Dwoskin LP, Allen DD, Lockman PR. Geldenhuys WJ, et al. Bioorg Med Chem Lett. 2010 Feb 1;20(3):870-7. doi: 10.1016/j.bmcl.2009.12.079. Epub 2009 Dec 28. Bioorg Med Chem Lett. 2010. PMID: 20053562 Free PMC article.

10

Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET.

Geldenhuys WJ, Funk MO, Barnes KF, Carroll RT. Geldenhuys WJ, et al. Bioorg Med Chem Lett. 2010 Feb 1;20(3):819-23. doi: 10.1016/j.bmcl.2009.12.088. Epub 2010 Jan 4. Bioorg Med Chem Lett. 2010. PMID: 20064719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters